229 related articles for article (PubMed ID: 28973694)
1. Editor's Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver.
Sriwattanapong K; Slocum SL; Chawanthayatham S; Fedeles BI; Egner PA; Groopman JD; Satayavivad J; Croy RG; Essigmann JM
Toxicol Sci; 2017 Nov; 160(1):173-179. PubMed ID: 28973694
[TBL] [Abstract][Full Text] [Related]
2. Food restriction reduces aflatoxin B1 (AFB1)-DNA adduct formation, AFB1-glutathione conjugation, and DNA damage in AFB1-treated male F344 rats and B6C3F1 mice.
Chou MW; Chen W
J Nutr; 1997 Feb; 127(2):210-7. PubMed ID: 9039820
[TBL] [Abstract][Full Text] [Related]
3. Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems.
Denissenko MF; Cahill J; Koudriakova TB; Gerber N; Pfeifer GP
Mutat Res; 1999 Apr; 425(2):205-11. PubMed ID: 10216213
[TBL] [Abstract][Full Text] [Related]
4. Effect of dietary restriction on glutathione S-transferase activity specific toward aflatoxin B1-8,9-epoxide.
Chen W; Nichols J; Zhou Y; Chung KT; Hart RW; Chou MW
Toxicol Lett; 1995 Aug; 78(3):235-43. PubMed ID: 7624894
[TBL] [Abstract][Full Text] [Related]
5. Dual effects of phloretin on aflatoxin B1 metabolism: activation and detoxification of aflatoxin B1.
Gao SS; Chen XY; Zhu RZ; Choi BM; Kim SJ; Kim BR
Biofactors; 2012; 38(1):34-43. PubMed ID: 22253071
[TBL] [Abstract][Full Text] [Related]
6. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture.
Langouët S; Coles B; Morel F; Becquemont L; Beaune P; Guengerich FP; Ketterer B; Guillouzo A
Cancer Res; 1995 Dec; 55(23):5574-9. PubMed ID: 7585637
[TBL] [Abstract][Full Text] [Related]
8. Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer.
Guengerich FP; Johnson WW; Ueng YF; Yamazaki H; Shimada T
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):557-62. PubMed ID: 8781383
[TBL] [Abstract][Full Text] [Related]
9. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
10. Prenatal exposure of mice to the human liver carcinogen aflatoxin B1 reveals a critical window of susceptibility to genetic change.
Chawanthayatham S; Thiantanawat A; Egner PA; Groopman JD; Wogan GN; Croy RG; Essigmann JM
Int J Cancer; 2015 Mar; 136(6):1254-62. PubMed ID: 25070670
[TBL] [Abstract][Full Text] [Related]
11. Low-dose microcystin-LR antagonizes aflatoxin B1 induced hepatocarcinogenesis through decreasing cytochrome P450 1A2 expression and aflatoxin B1-DNA adduct generation.
Wang L; He L; Zeng H; Fu W; Wang J; Tan Y; Zheng C; Qiu Z; Luo J; Lv C; Huang Y; Shu W
Chemosphere; 2020 Jun; 248():126036. PubMed ID: 32045972
[TBL] [Abstract][Full Text] [Related]
12. Glutathione-S-transferase activity toward aflatoxin epoxide in livers of mastomys and other rodents.
Esaki H; Kumagai S
Toxicon; 2002 Jul; 40(7):941-5. PubMed ID: 12076648
[TBL] [Abstract][Full Text] [Related]
13. Mouse strain differences in glutathione S-transferase activity and aflatoxin B1 biotransformation.
Borroz KI; Ramsdell HS; Eaton DL
Toxicol Lett; 1991 Sep; 58(1):97-105. PubMed ID: 1910216
[TBL] [Abstract][Full Text] [Related]
14. Low hepatic glutathione S-transferase and increased hepatic DNA adduction contribute to increased tumorigenicity of aflatoxin B1 in newborn and partially hepatectomized mice.
Shupe T; Sell S
Toxicol Lett; 2004 Mar; 148(1-2):1-9. PubMed ID: 15019083
[TBL] [Abstract][Full Text] [Related]
15. Aflatoxin B
Deng J; Zhao L; Zhang NY; Karrow NA; Krumm CS; Qi DS; Sun LH
Mutat Res Rev Mutat Res; 2018; 778():79-89. PubMed ID: 30454686
[TBL] [Abstract][Full Text] [Related]
16. Dietary restriction modulated carcinogen-DNA adduct formation and the carcinogen-induced DNA strand breaks.
Chou MW; Chen W; Mikhailova MV; Nichols J; Weis C; Jackson CD; Hart RW; Chung KT
Toxicol Lett; 1997 Jun; 92(1):21-30. PubMed ID: 9242354
[TBL] [Abstract][Full Text] [Related]
17. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males.
Yu MW; Chiang YC; Lien JP; Chen CJ
Carcinogenesis; 1997 Jun; 18(6):1189-94. PubMed ID: 9214602
[TBL] [Abstract][Full Text] [Related]
18. In vivo aflatoxin B1 metabolism and hepatic DNA adduction in zebrafish (Danio rerio).
Troxel CM; Reddy AP; O'Neal PE; Hendricks JD; Bailey GS
Toxicol Appl Pharmacol; 1997 Mar; 143(1):213-20. PubMed ID: 9073610
[TBL] [Abstract][Full Text] [Related]
19. Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exo-epoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo.
Stresser DM; Williams DE; McLellan LI; Harris TM; Bailey GS
Drug Metab Dispos; 1994; 22(3):392-9. PubMed ID: 8070315
[TBL] [Abstract][Full Text] [Related]
20. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines.
Macé K; Aguilar F; Wang JS; Vautravers P; Gómez-Lechón M; Gonzalez FJ; Groopman J; Harris CC; Pfeifer AM
Carcinogenesis; 1997 Jul; 18(7):1291-7. PubMed ID: 9230270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
